Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

Published:2021-08-19 Issue: Volume: Page:
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Duell Johannes,Maddocks Kami J.,González-Barca Eva,Jurczak Wojciech,Liberati Anna Marina,De Vos Sven,Nagy Zsolt,Obr Aleš,Gaidano Gianluca,Abrisqueta Pau,Kalakonda Nagesh,André Marc,Dreyling Martin,Menne Tobias,Tournilhac Olivier,Augustin Marinela,Rosenwald Andreas,Dirnberger-Hertweck Maren,Weirather Johannes,Ambarkhane Sumeet,Salles Gilles

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma;Human Vaccines & Immunotherapeutics;2024-02

2. Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice;Cancers;2023-11-13

3. Applications Using Real-World Evidence to Accelerate Medical Product Development;Real-World Evidence in Medical Product Development;2023

4. Treatments for Relapsed-Refractory Diffuse Large B-cell Lymphoma: A Preliminary Evaluation of the Place in Therapy of Glofitamab, a Bispecific Monoclonal Antibody;Cureus;2022-12-31

5. Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display;Frontiers in Immunology;2022-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP